EMA backs five med­i­cines; Sol­id Bio rais­es $60M in pri­vate place­ment

→ The Eu­ro­pean Med­i­cines Agency on Fri­day rec­om­mend­ed five new med­i­cines for ap­proval, in­clud­ing Bay­er’s can­cer drug Vi­t­rakvi — the site-ag­nos­tic can­cer drug was giv­en …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER